Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
34
COO Quote, Financials, Valuation and Earnings
Last price:
$71.05
Seasonality move
:
10.43%
Day range:
$69.84 - $72.10
52-week range:
$61.78 - $89.83
Dividend yield:
0%
P/E ratio:
34.60x
P/S ratio:
3.35x
P/B ratio:
1.63x
Volume:
1.9M
Avg. volume:
2.1M
1-year change:
-10.05%
Market cap:
$13.6B
Revenue:
$4.1B
EPS (TTM):
$2.02
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
$1B | $1.03 | 5.13% | 151.41% | $91.25 |
|
BLFE
Bio Life Sciences, Inc.
|
-- | -- | -- | -- | -- |
|
KIDS
OrthoPediatrics Corp.
|
$61.3M | -$0.29 | 11.31% | -4.82% | $24.89 |
|
MMSI
Merit Medical Systems, Inc.
|
$390.9M | $0.95 | 6.63% | 69.37% | $102.00 |
|
NXGL
NexGel, Inc.
|
$3.2M | -$0.09 | 6.54% | -22.68% | $2.00 |
|
STAA
STAAR Surgical Co.
|
$75.1M | $0.17 | 58.18% | 39.51% | $19.05 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
$69.92 | $91.25 | $13.6B | 34.60x | $0.01 | 0% | 3.35x |
|
BLFE
Bio Life Sciences, Inc.
|
$0.0001 | -- | $318.3K | -- | $0.00 | 0% | 0.05x |
|
KIDS
OrthoPediatrics Corp.
|
$17.31 | $24.89 | $437.6M | -- | $0.00 | 0% | 1.72x |
|
MMSI
Merit Medical Systems, Inc.
|
$69.95 | $102.00 | $4.2B | 32.90x | $0.00 | 0% | 2.79x |
|
NXGL
NexGel, Inc.
|
$0.83 | $2.00 | $6.8M | -- | $0.00 | 0% | 0.54x |
|
STAA
STAAR Surgical Co.
|
$18.84 | $19.05 | $932.8M | 49.73x | $0.00 | 0% | 3.92x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
23.01% | -0.333 | 15.74% | 0.62x |
|
BLFE
Bio Life Sciences, Inc.
|
-- | 0.000 | -- | -- |
|
KIDS
OrthoPediatrics Corp.
|
25.25% | -0.660 | 26.27% | 2.56x |
|
MMSI
Merit Medical Systems, Inc.
|
34.15% | -0.143 | 15.69% | 2.76x |
|
NXGL
NexGel, Inc.
|
38.1% | 1.099 | 15.76% | 0.82x |
|
STAA
STAAR Surgical Co.
|
10.03% | -0.104 | 3.36% | 3.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
$647.3M | $212.8M | 3.7% | 4.85% | 20.78% | $158.7M |
|
BLFE
Bio Life Sciences, Inc.
|
-- | -- | -- | -- | -- | -- |
|
KIDS
OrthoPediatrics Corp.
|
$39.4M | -$5.5M | -8.89% | -11.31% | -8.94% | $7.7M |
|
MMSI
Merit Medical Systems, Inc.
|
$195.4M | $54.1M | 5.59% | 8.67% | 13.72% | $73.3M |
|
NXGL
NexGel, Inc.
|
$1.2M | -$725K | -33.25% | -51.15% | -24.71% | -$793K |
|
STAA
STAAR Surgical Co.
|
$42.4M | -$10.9M | -20.36% | -22.57% | -18.83% | -$5.6M |
The Cooper Cos., Inc. vs. Competitors
-
Which has Higher Returns COO or BLFE?
Bio Life Sciences, Inc. has a net margin of 12.77% compared to The Cooper Cos., Inc.'s net margin of --. The Cooper Cos., Inc.'s return on equity of 4.85% beat Bio Life Sciences, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.63.21% $0.67 $10.9B BLFEBio Life Sciences, Inc.-- -- -- -
What do Analysts Say About COO or BLFE?
The Cooper Cos., Inc. has a consensus price target of $91.25, signalling upside risk potential of 30.51%. On the other hand Bio Life Sciences, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that The Cooper Cos., Inc. has higher upside potential than Bio Life Sciences, Inc., analysts believe The Cooper Cos., Inc. is more attractive than Bio Life Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 BLFEBio Life Sciences, Inc.0 0 0 -
Is COO or BLFE More Risky?
The Cooper Cos., Inc. has a beta of 1.018, which suggesting that the stock is 1.846% more volatile than S&P 500. In comparison Bio Life Sciences, Inc. has a beta of 106.319, suggesting its more volatile than the S&P 500 by 10531.944%.
-
Which is a Better Dividend Stock COO or BLFE?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Bio Life Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Bio Life Sciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or BLFE?
The Cooper Cos., Inc. quarterly revenues are $1B, which are larger than Bio Life Sciences, Inc. quarterly revenues of --. The Cooper Cos., Inc.'s net income of $130.8M is higher than Bio Life Sciences, Inc.'s net income of --. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 34.60x while Bio Life Sciences, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.35x versus 0.05x for Bio Life Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.3.35x 34.60x $1B $130.8M BLFEBio Life Sciences, Inc.0.05x -- -- --
-
Which has Higher Returns COO or KIDS?
OrthoPediatrics Corp. has a net margin of 12.77% compared to The Cooper Cos., Inc.'s net margin of -16.4%. The Cooper Cos., Inc.'s return on equity of 4.85% beat OrthoPediatrics Corp.'s return on equity of -11.31%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.63.21% $0.67 $10.9B KIDSOrthoPediatrics Corp.63.92% -$0.43 $463.7M -
What do Analysts Say About COO or KIDS?
The Cooper Cos., Inc. has a consensus price target of $91.25, signalling upside risk potential of 30.51%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.89 which suggests that it could grow by 43.78%. Given that OrthoPediatrics Corp. has higher upside potential than The Cooper Cos., Inc., analysts believe OrthoPediatrics Corp. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 KIDSOrthoPediatrics Corp.5 1 0 -
Is COO or KIDS More Risky?
The Cooper Cos., Inc. has a beta of 1.018, which suggesting that the stock is 1.846% more volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.075, suggesting its more volatile than the S&P 500 by 7.487%.
-
Which is a Better Dividend Stock COO or KIDS?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or KIDS?
The Cooper Cos., Inc. quarterly revenues are $1B, which are larger than OrthoPediatrics Corp. quarterly revenues of $61.6M. The Cooper Cos., Inc.'s net income of $130.8M is higher than OrthoPediatrics Corp.'s net income of -$10.1M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 34.60x while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.35x versus 1.72x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.3.35x 34.60x $1B $130.8M KIDSOrthoPediatrics Corp.1.72x -- $61.6M -$10.1M
-
Which has Higher Returns COO or MMSI?
Merit Medical Systems, Inc. has a net margin of 12.77% compared to The Cooper Cos., Inc.'s net margin of 9.64%. The Cooper Cos., Inc.'s return on equity of 4.85% beat Merit Medical Systems, Inc.'s return on equity of 8.67%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.63.21% $0.67 $10.9B MMSIMerit Medical Systems, Inc.49.58% $0.63 $2.4B -
What do Analysts Say About COO or MMSI?
The Cooper Cos., Inc. has a consensus price target of $91.25, signalling upside risk potential of 30.51%. On the other hand Merit Medical Systems, Inc. has an analysts' consensus of $102.00 which suggests that it could grow by 45.82%. Given that Merit Medical Systems, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Merit Medical Systems, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 MMSIMerit Medical Systems, Inc.4 2 0 -
Is COO or MMSI More Risky?
The Cooper Cos., Inc. has a beta of 1.018, which suggesting that the stock is 1.846% more volatile than S&P 500. In comparison Merit Medical Systems, Inc. has a beta of 0.618, suggesting its less volatile than the S&P 500 by 38.184%.
-
Which is a Better Dividend Stock COO or MMSI?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Merit Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Merit Medical Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or MMSI?
The Cooper Cos., Inc. quarterly revenues are $1B, which are larger than Merit Medical Systems, Inc. quarterly revenues of $394.2M. The Cooper Cos., Inc.'s net income of $130.8M is higher than Merit Medical Systems, Inc.'s net income of $38M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 34.60x while Merit Medical Systems, Inc.'s PE ratio is 32.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.35x versus 2.79x for Merit Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.3.35x 34.60x $1B $130.8M MMSIMerit Medical Systems, Inc.2.79x 32.90x $394.2M $38M
-
Which has Higher Returns COO or NXGL?
NexGel, Inc. has a net margin of 12.77% compared to The Cooper Cos., Inc.'s net margin of -22.05%. The Cooper Cos., Inc.'s return on equity of 4.85% beat NexGel, Inc.'s return on equity of -51.15%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.63.21% $0.67 $10.9B NXGLNexGel, Inc.40.93% -$0.08 $8.8M -
What do Analysts Say About COO or NXGL?
The Cooper Cos., Inc. has a consensus price target of $91.25, signalling upside risk potential of 30.51%. On the other hand NexGel, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 140.67%. Given that NexGel, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe NexGel, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 NXGLNexGel, Inc.0 0 0 -
Is COO or NXGL More Risky?
The Cooper Cos., Inc. has a beta of 1.018, which suggesting that the stock is 1.846% more volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or NXGL?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or NXGL?
The Cooper Cos., Inc. quarterly revenues are $1B, which are larger than NexGel, Inc. quarterly revenues of $2.9M. The Cooper Cos., Inc.'s net income of $130.8M is higher than NexGel, Inc.'s net income of -$647K. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 34.60x while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.35x versus 0.54x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.3.35x 34.60x $1B $130.8M NXGLNexGel, Inc.0.54x -- $2.9M -$647K
-
Which has Higher Returns COO or STAA?
STAAR Surgical Co. has a net margin of 12.77% compared to The Cooper Cos., Inc.'s net margin of -31.68%. The Cooper Cos., Inc.'s return on equity of 4.85% beat STAAR Surgical Co.'s return on equity of -22.57%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.63.21% $0.67 $10.9B STAASTAAR Surgical Co.73.37% -$0.37 $382.5M -
What do Analysts Say About COO or STAA?
The Cooper Cos., Inc. has a consensus price target of $91.25, signalling upside risk potential of 30.51%. On the other hand STAAR Surgical Co. has an analysts' consensus of $19.05 which suggests that it could grow by 1.12%. Given that The Cooper Cos., Inc. has higher upside potential than STAAR Surgical Co., analysts believe The Cooper Cos., Inc. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 STAASTAAR Surgical Co.1 10 1 -
Is COO or STAA More Risky?
The Cooper Cos., Inc. has a beta of 1.018, which suggesting that the stock is 1.846% more volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.046, suggesting its more volatile than the S&P 500 by 4.569%.
-
Which is a Better Dividend Stock COO or STAA?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or STAA?
The Cooper Cos., Inc. quarterly revenues are $1B, which are larger than STAAR Surgical Co. quarterly revenues of $57.8M. The Cooper Cos., Inc.'s net income of $130.8M is higher than STAAR Surgical Co.'s net income of -$18.3M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 34.60x while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 3.35x versus 3.92x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.3.35x 34.60x $1B $130.8M STAASTAAR Surgical Co.3.92x 49.73x $57.8M -$18.3M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 34x
Sell
34
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
56
ORKA alert for Mar 16
Oruka Therapeutics, Inc. [ORKA] is up 4.6% over the past day.
Buy
100
APEI alert for Mar 16
American Public Education, Inc. [APEI] is down 4.18% over the past day.
Sell
40
GDXD alert for Mar 16
MicroSectors Gold Miners -3X Inverse Leveraged ETN [GDXD] is down 3.77% over the past day.
